Abbott Laboratories get FDA clearance for Chlamydia/Gonorrhea molecular assay

Co-infection with Chlamydia trachomatis and Neisseria gonorrhoeae is very common and detection of both of these sexually transmitted infections is important to ensure appropriate treatment is given.

Abbott Laboratories has just received FDA approval of the Abbott m2000 system, and the Abbott RealTime Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) test. They must be used together to detect these pathogens from a variety of clinical samples to include urine, urethral, vaginal and endocervical.